Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine

By Tarr P.E.   Lin R.   Mueller E.A.   Kovarik J.M.   Guillaumes M.   Jones T.C.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1199-1204

Elsevier

Access to resources Recommend Favorite

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

By Sin J.-I.   Sung J.-H.   Suh Y.-S.   Lee A.-H.   Chung J.-H.   Sung Y.-C.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1827-1833

Elsevier

Access to resources Recommend Favorite

Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus

By Fukushima A.   Yoo Y.C.   Yoshimatsu K.   Matsuzawa K.   Tamura M.   Tono-oka S.   Taniguchi K.   Urasawa S.   Arikawa J.   Azuma I.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 485-491

Elsevier

Access to resources Recommend Favorite

Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

By Argiro L.   Henri S.   Dessein H.   Dessein A.J.   Bourgois A.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 13-18

Elsevier

Access to resources Recommend Favorite

Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice

By Li T.-C.   Takeda N.   Miyamura T.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3476-3484

Elsevier

Access to resources Recommend Favorite